Dropbox CEO Drew Houston to Step Down After 19Year Tenure Becomes Executive Chairman Gold Technical Analysis Key Levels and Market Dynamics Ahead CNBC Investing Club Portfolio Rides Market Rally Top and Bottom Performers Emerge in SixWeek Surge Iran Standoff Intensifies as Trump Rejects Counteroffer Strait of Hormuz Tensions Escalate Rosen Law Firm Reminds Pinterest Investors of Lead Plaintiff Deadline in Securities Class Action Intel Pushes PC Makers Toward 18A Chips as AI Demand Surges Margin Boost Potential SCVL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment PRHIZ Q1 2024 Earnings Strong EPS Surprise Despite No Revenue Reported XEL Q1 2026 Earnings Slight EPS Miss Amid Stable Operations NIO Q1 2026 Earnings Narrower Loss Surprises as Stock Sheds Gains Kodiak AI Inc Q1 2026 Earnings EPS Surges Past Estimates Stock Slips on Revenue Uncertainty GCBC Q2 2025 Earnings Solid EPS of 044 Despite Absence of Consensus Estimates OCCIM Preferred Shares Hold Steady at 2530 Amid Market Stability Treace Medical Concepts TMCI Surges 6 as Shares Test Key Resistance Level Arena Group Holdings AREN Shares Edge Higher as Support Level Holds GameStop GME Pulls Back Support Levels Under Scrutiny After 236 Decline CapsoVision CV Holds Steady Near Key Support Amid Low Volatility Berkshire Hathaway Builds 26 Billion Delta Air Lines Stake Marking Return to Airlines Vanda Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates Stock Advances Despite Wider Loss Coeptis Therapeutics Holdings Inc COEP Holds Steady Near Support After Flat Trading Day KORE Group Holdings Inc KORE Holds Steady at 918 as Traders Eye Key Levels Insight Digital Partners II DYOR Holds Near Support Amid Low Volatility Quantumsphere Acquisition Corp QUMS Holds Steady at 1019 as Trading Range Narrows Oculis Holding AG Warrants OCSAW Hold Steady Near Support as Market Awaits Catalysts Morgan Stanley Emerging Markets Debt Fund Inc MSD Holds Steady Near Resistance Amid Modest Uptick Nuburu Inc BURU Stock Slides 65 as Share Price Nears Critical Support at 017 Perspective Therapeutics CATX Gains 284 as Stock Nears Key Resistance at 418